Downloads
Precision Neuroimaging in a Global Phase 1 Parkinson's Disease Clinical Trial
IXICO supported a 6-year, multinational clinical trial involving over 250 participants across more than 220 sites, delivering precision neuroimaging to assess Parkinson’s disease biomarkers.
Huntington's Disease: Your Imaging Analysis & Operations Solutions Partner
Transforming clinical research in Huntington’s diseaseEstablished for over 20 years, IXICO is the leading provider of neuroimaging services for Huntington’s disease (HD) clinical trials. Our mission is to advance investigational therapies through innovative imaging solutions that comply with global regulatory standards. Download the Factsheet here to share with your colleagues and network
Your Imaging Analysis & Operations Experts in Alzheimer’s Disease Clinical Research
IXICO’s Alzheimer’s Disease Footprint at a GlanceClick below to download this factsheet and share with your colleagues or network Pioneering Precision in AD Imaging IXICO excels in AD imaging with advanced imaging biomarkers to quantify markers such as amyloid plaques, tau tangles, and brain atrophy. Our AI-driven IXIQ.
Executing a Multi-Arm Phase 1 Alzheimer’s Disease Global Clinical Trial with Clinilabs and IXICO
In the realm of Central Nervous System (CNS) clinical trials, the expertise in science and technology is constantly being pushed to new boundaries.